NCT03420131 - Diagnostic Agreement of iFR and QFR. | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

July 18, 2017

Primary Completion Date

July 28, 2018

Study Completion Date

October 1, 2018

Conditions

Fractional Flow Reserve, MyocardialCoronary Artery Disease

Interventions

DIAGNOSTIC_TEST

QFR and iFR

"iFR® (CE-Marked) is a pressure-derived, hyperemia-free index for the assessment of coronary stenosis relevance. This option consists of an FFR-iFR® specific patient interface module (PIM-FFR) which can be connected to the Volcano system - VOLCANO s5 or s5i™ platform equipped with iFR® option.~QFR® (CE-Marked) is an angio-based FFR estimation using the analytical Software QAngio XA 3D from Medis medical imaging B.V., The Netherland"

Trial Locations (1)

45138

RECRUITING

Contilia heart and vascular center, Essen